Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014 (2014), Article ID 959471, 10 pages
http://dx.doi.org/10.1155/2014/959471
Research Article

A Novel Chemically Modified Curcumin Reduces Severity of Experimental Periodontal Disease in Rats: Initial Observations

1Department of Oral Biology and Pathology, School of Dental Medicine, Stony Brook University, Stony Brook, NY 11794, USA
2Department of Diagnosis and Surgery, School of Dentistry at Araraquara, UNESP, 14801-903 Araraquara, SP, Brazil
3Department of Chemistry, Stony Brook University, Stony Brook, NY 11794-3400, USA

Received 28 February 2014; Revised 1 May 2014; Accepted 19 May 2014; Published 29 June 2014

Academic Editor: Fabio S. Lira

Copyright © 2014 Muna S. Elburki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Hu, P. E. Van den Steen, Q. A. Sang, and G. Opdenakker, “Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases,” Nature Reviews Drug Discovery, vol. 6, no. 6, pp. 480–498, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Sorsa, L. Tjäderhane, Y. T. Konttinen et al., “Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation,” Annals of Medicine, vol. 38, no. 5, pp. 306–321, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. C. M. Overall and C. López-Otín, “Strategies for MMP inhibition in cancer: innovations for the post-trial era,” Nature Reviews Cancer, vol. 2, pp. 657–672, 2002. View at Google Scholar
  4. Y. Gu, C. Walker, M. E. Ryan, J. B. Payne, and L. M. Golub, “Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicine,” Journal of Oral Microbiology, vol. 4, Article ID 19227, 2012. View at Publisher · View at Google Scholar
  5. K. Frankwich, C. Tibble, M. Torres-Gonzalez et al., “Proof of concept: matrix metalloproteinase inhibitor decreases inflammation and improves muscle insulin sensitivity in people with type 2 diabetes,” Journal of Inflammation, vol. 9, article 35, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. P. Engebretson and J. Hey-Hadavi, “Sub-antimicrobial doxycycline for periodontitis reduces hemoglobin A1c in subjects with type 2 diabetes: a pilot study,” Pharmacological Research, vol. 64, no. 6, pp. 624–629, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. L. M. Golub, H. M. Lee, R. A. Greenwald et al., “A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis,” Inflammation Research, vol. 46, no. 8, pp. 310–319, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. L. M. Golub, N. S. Ramamurthy, T. F. McNamara, R. A. Greenwald, and B. R. Rifkin, “Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs,” Critical Reviews in Oral Biology and Medicine, vol. 2, no. 3, pp. 297–321, 1991. View at Google Scholar · View at Scopus
  9. L. M. Golub, H. M. Lee, M. E. Ryan, W. V. Giannobile, J. Payne, and T. Sorsa, “Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms,” Advances in dental research, vol. 12, no. 2, pp. 12–26, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. J. B. Payne and L. M. Golub, “Using tetracyclines to treat osteoporotic/osteopenic bone loss: from the basic science laboratory to the clinic,” Pharmacological Research, vol. 63, no. 2, pp. 121–129, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Gu, H. M. Lee, N. Napolitano et al., “4-methoxycarbonyl curcumin: a unique inhibitor of both inflammatory mediators and periodontal inflammation,” Mediators of Inflammation, vol. 2013, Article ID 329740, 10 pages, 2013. View at Publisher · View at Google Scholar
  12. A. R. Amin, M. Attur, and S. B. Abramson, “Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis,” Current Opinion in Rheumatology, vol. 11, no. 3, pp. 202–209, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Zhang, Y. Gu, H. M. Lee et al., “Design, synthesis and biological activity of new polyenolic inhibitors of matrix metalloproteinases: a focus on chemically-modified curcumins,” Current Medicinal Chemistry, vol. 19, no. 25, pp. 4348–4358, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Zhang, L. M. Golub, F. Johnson, and A. Wishnia, “PKa, Zinc- and serum albumin-binding of curcumin and two novel biologically-active chemically-modified curcumins,” Current Medicinal Chemistry, vol. 19, no. 25, pp. 4367–4375, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. G. I. Botchkina, E. S. Zuniga, R. H. Rowehl et al., “Prostate cancer stem cell-targeted efficacy of a new-generation taxoid , SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24,” PLoS ONE, vol. 8, no. 9, Article ID e69884, 2013. View at Publisher · View at Google Scholar
  16. M. R. Guimarães, L. S. Coimbra, S. G. De Aquino, L. C. Spolidorio, K. L. Kirkwood, and C. Rossa, “Potent anti-inflammatory effects of systemically administered curcumin modulate periodontal disease in vivo: curcumin inhibits periodontal disease in vivo,” Journal of Periodontal Research, vol. 46, no. 2, pp. 269–279, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. B. Payne, L. M. Golub, J. A. Stoner et al., “The effect of subantimicrobial-dosedoxycycline periodontal therapy on serum biomarkers of systemic inflammation: A randomized, double-masked, placebo-controlled clinical trial,” Journal of the American Dental Association, vol. 142, no. 3, pp. 262–273, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Garcia de Aquino, F. R. Manzolli Leite, D. R. Stach-Machado, J. A. Francisco da Silva, L. C. Spolidorio, and C. Rossa Jr., “Signaling pathways associated with the expression of inflammatory mediators activated during the course of two models of experimental periodontitis,” Life Sciences, vol. 84, no. 21-22, pp. 745–754, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. N. S. Ramamurthy and L. M. Golub, “Diabetes increases collagenase activity in extracts of rat gingiva and skin,” Journal of Periodontal Research, vol. 18, no. 1, pp. 23–30, 1983. View at Publisher · View at Google Scholar · View at Scopus
  20. L. M. Golub, R. T. Evans, T. F. McNamara, H. M. Lee, and N. S. Ramamurthy, “A non-antimicrobial tetracycline inhibits gingival matrix metalloproteinases and bone loss in Porphyromonas gingivalis-induced periodontitis in rats,” Annals of the New York Academy of Sciences, vol. 732, pp. 96–111, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Lee, S. G. Ciancio, G. Tüter, M. E. Ryan, E. Komaroff, and L. M. Golub, “Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patient is enhanced when combined with a non-steriodal anti-inflammatory drug,” Journal of Periodontology, vol. 75, no. 3, pp. 453–463, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. D. L. Brown, K. K. Desai, B. A. Vakili, C. Nouneh, H. Lee, and L. M. Golub, “Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 4, pp. 733–738, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. D. M. de Souza, F. A. de Prado, M. A. de Prado, R. F. da Rocha, and Y. R. de Carvalho, “Evaluation of two morphometric methods of bone loss percentages caused by periodontitis in rats in different locations,” Journal of Applied Oral Science, vol. 18, no. 5, pp. 493–497, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. L. M. Golub, T. Sorsa, H. M. Lee et al., “Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva,” Journal of Clinical Periodontology, vol. 22, no. 2, pp. 100–109, 1995. View at Google Scholar · View at Scopus
  25. A. C. Bharti, Y. Takada, and B. B. Aggarwal, “Curcumin ( diferuloylmethane ) inhibits receptor activator of NF- κB ligand-induced NF- κB activation in osteoclast precursors and suppresses osteoclastogenesis,” The Journal of Immunology, vol. 172, no. 10, pp. 5940–5947, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Grynkiewicz and P. Ślifirski, “Curcumin and curcuminoids in quest for medicinal status,” Acta Biochimica Polonica, vol. 59, no. 2, pp. 201–212, 2012. View at Google Scholar · View at Scopus
  27. M. Woo, S. Jung, S. Kim et al., “Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells,” Biochemical and Biophysical Research Communications, vol. 335, no. 4, pp. 1017–1025, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Banerji, J. Chakrabarti, A. Mitra, and A. Chatterjee, “Effect of curcumin on gelatinase a (MMP-2) activity in B16F10 melanoma cells,” Cancer Letters, vol. 211, no. 2, pp. 235–242, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Shakibaei, T. John, G. Schulze-Tanzil, I. Lehmann, and A. Mobasheri, “Suppression of NF-κB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: implications for the treatment of osteoarthritis,” Biochemical Pharmacology, vol. 73, no. 9, pp. 1434–1445, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Kaur, N. Tirkey, S. Bharrhan, V. Chanana, P. Rishi, and K. Chopra, “Inhibition of oxidative stress and cytokine activity by curcumin in amelioration of endotoxin-induced experimental hepatoxicity in rodents,” Clinical and Experimental Immunology, vol. 145, no. 2, pp. 313–321, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. A. N. Begum, M. R. Jones, G. P. Lim et al., “Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease,” Journal of Pharmacology and Experimental Therapeutics, vol. 326, no. 1, pp. 196–208, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. C. N. Serhan, N. Chiang, and T. E. Van Dyke, “Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators,” Nature Reviews Immunology, vol. 8, no. 5, pp. 349–361, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Katzap, M. J. Goldstein, N. V. Shah et al., “The chondroprotective properties of curcumin (Curcuma longa) and curcumin derived polyenolic zinc binding inhibitors against IL-1β and OsM -induced chrondrolysis,” Transactions of the Orthopedic Research Society, vol. 36, 2011. View at Google Scholar
  34. L. M. Golub, H. M. Lee, J. A. Stoner et al., “Doxycycline effects on serum bone biomarkers in post-menopausal women,” Journal of Dental Research, vol. 89, no. 6, pp. 644–649, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. M. R. Guimarães, S. G. de Aquino, L. S. Coimbra, L. C. Spolidorio, K. L. Kirkwood, and C. Rossa Jr., “Curcumin modulates the immune response associated with LPS-induced periodontal disease in rats,” Innate Immunity, vol. 18, no. 1, pp. 155–163, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. J. A. C. de Souza, C. Rossa Junior, G. P. Garlet, A. V. B. Nogueira, and J. A. Cirelli, “Modulation of host cell signaling pathways as a therapeutic approach in periodontal disease,” Journal of Applied Oral Science, vol. 20, no. 2, pp. 128–138, 2012. View at Publisher · View at Google Scholar · View at Scopus